Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
Status:
Completed
Trial end date:
2018-11-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with sitagliptin reduces the
frequency and severity of high blood sugar (hyperglycemia) after cardiac surgery and to
determine whether treatment with sitagliptin is effective in maintaining blood sugar control
in patients with type 2 diabetes (T2D).